Evolution of HTLV-1 proviral load in patients from Salvador, Brazil

Brazilian Journal of Infectious Diseases

Volumn 16, Issue 4, 2012, Pages 357-360

  Nilla Olavarria, Viviana ^a,b   Nascimento Gomes, Alline do ^b   de Almeida Kruschewsky, Ramon ^b   Galvão Castro, Bernardo ^a,b   Rios Grassi, Maria Fernanda ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

Author keywords

Asymptomatic; Evolution; HAM TSP; HTLV 1; Proviral load

Indexed keywords

ADULT; ARTICLE; ASYMPTOMATIC INFECTION; BRAZIL; CONTROLLED STUDY; FEMALE; HTLV 1 ASSOCIATED MYELOPATHY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; MAJOR CLINICAL STUDY; MALE; MOLECULAR EVOLUTION; PATHOGEN LOAD; PATIENT MONITORING; PERIODICITY; PROVIRUS LOAD; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TROPICAL SPASTIC PARAPARESIS;

ADULT; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MALE; MIDDLE AGED; PARAPARESIS, TROPICAL SPASTIC; PROVIRUSES; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; VIRAL LOAD; YOUNG ADULT;

EID: 84864349132     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2012.06.022     Document Type: Article

References (26)

1. Proietti F.A., Carneiro-Proietti A.B., Catalan-Soares B.C., Murphy E.L. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005, 39:6058-6068.
2. Dourado I., Alcantara L.C., Barreto M.L., Da Gloria Teixeira M., Galvão-Castro B. HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics. J Acquir Immune Defic Syndr 2003, 5:527-531.
3. Gessain A., Barin F., Vernant J.C., et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985, 8452:407-410.
4. Osame M., Usuku K., Izumo S., et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986, 8488:1031-1032.
5. Mochizuki M., Yamaguchi K., Takatsuki K., Watanabe T., Mori S., Tajima K. HTLV-I and uveitis. Lancet 1992, 8801:1110.
6. Castro-Lima Vargens C., Grassi M.F., Boa-Sorte N., et al. Keratoconjunctivitis sicca of human T cell lymphotropic virus type 1 (HTLV-1) infected individuals is associated with high levels of HTLV-1 proviral load. J Clin Virol 2011, 3:177-180.
7. Lagrenade L., Hanchard B., Fletcher V., Cranston B., Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 1990, 8727:1345-1347.
8. Marinho J., Galvao-Castro B., Rodrigues L.C., Barreto M.L. Increased risk of tuberculosis with human T-lymphotropic virus-1 infection: a case-control study. J Acquir Immune Defic Syndr 2005, 5:625-628.
9. Verdonck K., Gonzalez E., Henostroza G., et al. HTLV-1 infection is frequent among out-patients with pulmonary tuberculosis in northern Lima, Peru. Int J Tuberc Lung Dis 2007, 10:1066-1072.
10. Nakada K., Kohakura M., Komoda H., Hinuma Y. High incidence of HTLV antibody in carriers of Strongyloides stercoralis. Lancet 1984, 8377:633.
11. Porto M.A., Muniz A., Oliveira Junior J., Carvalho E.M. Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis. Rev Soc Bras Med Trop 2002, 6:641-649.
12. Brites C., Weyll M., Pedroso C., Badaro R. Severe and Norwegian scabies are strongly associated with retroviral (HIV-1/HTLV-1) infection in Bahia, Brazil. AIDS 2002, 9:1292-1293.
13. Nagai M., Usuku K., Matsumoto W., et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998, 6:586-593.
14. Olindo S., Lezin A., Cabre P., et al. HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression. J Neurol Sci 2005, 1-2:53-59.
15. Grassi M.F.R., Olavarria V., Kruschewsky R.A., et al. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP. J Med Virol 2011, 83:1269-1274.
16. Jeffery K.J., Usuku K., Hall S.E., et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A 1999, 7:3848-3853.
17. Taylor G.P., Tosswill J.H., Matutes E., et al. Prospective study of HTLV-I infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr 1999, 1:92-100.
18. Manns A., Miley W.J., Wilks R.J., et al. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection. J Infect Dis 1999, 5:1487-1493.
19. Kwaan N., Lee T.H., Chafets D.M., et al. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data. J Infect Dis 2006, 11:1557-1564.
20. Kubota R., Fujiyoshi T., Izumo S., et al. Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy. J Neuroimmunol 1993, 2:147-154.
21. Furtado Mdos S., Andrade R.G., Romanelli, et al. Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease. J Med Virol 2012, 4:664-671.
22. Primo J., Siqueira I., Nascimento M.C., et al. High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1. Braz J Med Biol Res 2009, 8:761-764.
23. Okayama A., Stuver S., Matsuoka M., et al. Role of HTLV-1 proviral DNA load and clonality in the development of adult T-cell leukemia/lymphoma in asymptomatic carriers. Int J Cancer 2004, 4:621-625.
24. Yakova M., Lezin A., Dantin F., et al. Increased proviral load in HTLV-1-infected patients with rheumatoid arthritis or connective tissue disease. Retrovirology 2005, 2:4.
25. Asquith B., Bangham C.R. Quantifying HTLV-I dynamics. Immunol Cell Biol 2007, 4:280-286.
26. Bangham C.R., Meekings K., Toulza F., et al. The immune control of HTLV-1 infection: selection forces and dynamics. Front Biosci 2009, 14:2889-2903.